Company intelligence / Profile preview

Stena Sessan

Gothenburg, Sweden

Ownership: Private
Employees: ~15
Development stage: Other

Overview

Stena Sessan is a Swedish investment company and part of the Stena Sphere, owned by the Olsson family. The firm focuses on long-term investments in companies with strong growth potential, with a significant strategic emphasis on the healthcare and life sciences sectors. Its portfolio includes notable holdings in medical technology, biotechnology, and specialty pharmaceuticals, such as Hansa Biopharma, Calliditas Therapeutics, and AddLife. Stena Sessan acts as an active owner, providing capital and industrial expertise to support the development of its partner companies.

Therapeutic areas: ImmunologyNephrologyRare DiseasesInfectious Diseases
Modalities: Small moleculeMonoclonal antibodyVaccineBioprintingMedical Device
Industry: Investors

Beyond the preview

Go deeper on Stena Sessan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stena Sessan.

Explore the full profile